Iambic Therapeutics Files for US IPO with Nvidia Support
Biotech firm Iambic Therapeutics has filed for an initial public offering in the United States. The company, which is backed by Nvidia, aims to leverage artificial intelligence to transform drug discovery processes.
Summaries are written by AI from the original article. Not investment advice.